Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Factor Therapeutics.
RELATED STOCKHEAD STORIES
News
Factor Therapeutics back to square one after proposed vet imaging deal falls over
Health & Biotech
Check up: A good fortnight to be a small cap health investor
Health & Biotech
Check up: Maybe next week will be better?
Health & Biotech
Factor Therapeutics may finally have found its future — in veterinary imaging
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
RAMCap wants to turn Factor Therapeutics into a hedge fund business
Health & Biotech
Check up: The COVID-crisis strikes leaving just 9 stocks in the black
Health & Biotech
My bank balance is bigger than yours: biotech quarterlies
Health & Biotech
9 of the most interesting biotech bosses in the game today: part 1
News
Corporate: Factor Therapeutics still looking for its next opportunity
Health & Biotech
When is the right time for a biotech to try and woo big pharma?
Health & Biotech
Health: Elixinol pivots to pet pot treats, nabs 25pc stake in US hemp manufacturer
News
Corporate: Oilex wants to put its legal ruckus with Indian partner to bed
News
Weststar wins $2.7m in precast concrete contracts
Check-up: What’s happening with the ASX small cap health stocks?
Health & Biotech
‘Mice are a failed experiment’: Why you shouldn’t get revved up about pre-clinical trials
News
